Aquestive Therapeutics (AQST) Other Gross PP&E Adjustments (2017 - 2025)
Aquestive Therapeutics (AQST) has 8 years of Other Gross PP&E Adjustments data on record, last reported at $41.5 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 17.74% year-over-year to $41.5 million; the TTM value through Dec 2025 reached $41.5 million, up 17.74%, while the annual FY2025 figure was $41.5 million, 17.74% up from the prior year.
- Other Gross PP&E Adjustments reached $41.5 million in Q4 2025 per AQST's latest filing, down from $41.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $43.4 million in Q3 2022 and bottomed at $35.3 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is $40.8 million, with a median of $41.0 million recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: fell 11.33% in 2024, then grew 17.74% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $40.5 million in 2021, then fell by 3.41% to $39.1 million in 2022, then increased by 1.73% to $39.8 million in 2023, then dropped by 11.33% to $35.3 million in 2024, then increased by 17.74% to $41.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $41.5 million in Q4 2025, $41.9 million in Q3 2025, and $42.3 million in Q2 2025.